Novavax, Inc (NASDAQ:NVAX) concluded the trading at $8.10 on Wednesday, March 12 with a rise of 2.27% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $7.92 and 5Y monthly beta was
Novavax, Inc (NASDAQ:NVAX) traded at $8.34 at close of the session on Friday, March 07 and made an upward move of 5.97% on its previous day’s price. Novavax, Inc has a market cap of $1.34 billion and is expected to release its quarterly earnings report
Novavax, Inc (NASDAQ:NVAX) shares, rose in value, with the stock price up by 2.73% to the previous day’s close as strong demand from buyers drove the stock to $7.89. Actively observing the price movement in the last trading, the stock closed the session at $7.68.
Shares of US biotech company Novavax at the August 5 aftermarket trading rose 5%, then plunged more than 17% to $204.76 each. The plunge was in response to the upcoming transfer of the application to the United States Food and Drug Administration (FDA) for approval
In the biotechnology industry, companies produce drugs that treat illness and diagnostic technologies. For these products to be approved by the FDA, the process is lengthy and expensive. Food and Drug Administration (FDA). In this case, investors may have to wait years to find out
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
